Gain Therapeutics to Participate at the Imagine AI + Healthcare Investor Summit
01 déc. 2021 16h07 HE
|
Gain Therapeutics
BETHESDA, Md., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company focused on identifying and optimizing allosteric binding sites that have...
Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update
12 nov. 2021 07h00 HE
|
Gain Therapeutics
Data from Patient-Derived iPSC Study Evaluating STAR Compounds Show Positive Effects on Disease Onset and Progression; Full Data Presented at MJFF’s Parkinson's Disease Therapeutics Conference---...
Gain Therapeutics Presents Parkinson’s Disease Preclinical Study Results at Society for Neuroscience Annual Meeting
11 nov. 2021 11h00 HE
|
Gain Therapeutics
BETHESDA, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding...
Gain Therapeutics, Inc. Announces Breakthrough Pre-Clinical Data of Novel Small Molecules for the Treatment of Parkinson’s Disease and Gaucher Disease
10 nov. 2021 11h00 HE
|
Gain Therapeutics
Study results demonstrate first small molecule approach to significantly reduce phosphorylated and aggregated -synuclein and increase GCase protein levels with transport to the lysosomes in iPSC...
Gain Therapeutics to Present at the 12th Annual Jefferies London Healthcare Conference
04 nov. 2021 16h05 HE
|
Gain Therapeutics
In-Person Dates: November 16th-17thVirtual Dates: November 18th-19th BETHESDA, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a...
Gain Therapeutics to Present at Upcoming Medical Conferences
28 oct. 2021 08h00 HE
|
Gain Therapeutics
- The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Webinars - - Society of Neuroscience 50th Anniversary Meeting – BETHESDA, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Gain...
Gain Therapeutics, Inc. Announces Appointment of Five Members to its Newly Formed Scientific Advisory Board (SAB)
26 oct. 2021 08h00 HE
|
Gain Therapeutics
BETHESDA, Md., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “company”), a biotechnology company focused on identifying and optimizing allosteric binding...
Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer
19 oct. 2021 08h00 HE
|
Gain Therapeutics
BETHESDA, Md., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding...
Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
23 sept. 2021 08h00 HE
|
Gain Therapeutics
BETHESDA, Md., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding...
Gain Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
17 sept. 2021 08h00 HE
|
Gain Therapeutics
- Conference Dates: September 20th-23rd - BETHESDA, Md., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on...